• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Tinaquant IgA Gen.2 immunoturbidimetric assay

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Tinaquant IgA Gen.2 immunoturbidimetric assaysee related information
Date Initiated by FirmJune 03, 2019
Create DateJuly 16, 2019
Recall Status1 Terminated 3 on August 28, 2020
Recall NumberZ-1979-2019
Recall Event ID 83095
510(K)NumberK040435 
Product Classification Iga, antigen, antiserum, control - Product Code CZP
ProductThe Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically.
Code Information Lot 368756
FEI Number 1823260
Recalling Firm/
Manufacturer
Roche Diagnostics Corporation
9115 Hague Rd
Indianapolis IN 46256-1025
For Additional Information ContactRoche Support Network Customer Support Center
800-428-2336
Manufacturer Reason
for Recall
Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.
FDA Determined
Cause 2
Material/Component Contamination
ActionUrgent Medical Device Correction notification letters dated 6/3/19 were sent to customers.
Quantity in Commerce8 units
DistributionThe products were distributed to the following US states: AL, IN, and KY.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
510(K) Database510(K)s with Product Code = CZP
-
-